cancer does not have receptors for estrogen or the related hormone progesterone and is also negative for overexpression of the HER2 protein, a type of protein fueled by a certain gene, also calledHER2, that contributes to cancer cell growth. This limits the number of effective treatment options....
A number of chemotherapy options are available in metastatic breast cancer. Many of the regimens are found to be beneficial as single agents and some are effective as combination agents. In majority of the patients, since the goal of treatment is palliation, it is important to consider the ...
Bradley J. Monk, MD, FACS, FACOG, reviews the available chemotherapy options for treating advanced and recurrent endometrial cancer, as well as compares notes with Christian Marth, MD, PhD, on his clinical experience. EP: 1.An Overview of Endometrial Cancer Now Viewing EP: 2.Chemotherapy Opti...
Treatment Options for Breast Cancer Most breast cancer is treated with surgery — a lumpectomy or mastectomy— often along with radiation or other treatments to rid the body of cancer cells, such as chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Surgery for Breast Cancer Lumpec...
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cell lung cancer (SCLC). Re... S Cheng,WK Evans,D Stys-Norman,... - 《...
Al-Shehri A, Skedgel C, Rayson D et al (2005) Cost evaluation of Second Generation Adjuvant Chemotherapy Options in Breast Cancer. Breast Cancer Res Treat 94(S1):S219 (abstr 5041) 22. Statistics Canada. Consumer Price Index (Health Care). http://www.cansim2.statcan.ca/...
New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones. Drugs 2008;68:139-46.Pronzato P. New therapeutic options for chemotherapy-resistant metastat- ic breast cancer: the epothilones. Drugs 2008;68:139-46....
De Rosa L, Lalle M, Pandolfi A, Pescador L (2001) Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer. Bone Marrow Transplant 27:1031–1035De-Rosa L,Lalle M,Pandolfi A,etc.Costs of high-dose chemotherapy and peripheral blood progenitor cell ...
"Metastatic triple-negative breast cancer is an aggressive form of breast cancer with limited treatment options. Chemotherapy has been the mainstay of treatment for triple-negative breast cancer," FDA Oncology Center of Excellence Director Dr. Richard Pazdur said in a statement. ...
Neoadjuvant chemotherapy for breast cancer is a strategy that was introduced towards the end of the 20th century with the aim of reducing tumour size. It has four main rationales. First, it should render an otherwise inoperable tumour operable or, second, allow more conservative surgery. Third, ...